Skip to main content

Abbott Laboratories

ABT
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000001800

In the last 90 days, Abbott Laboratories insiders filed 0 open-market purchases and 3 sales; 2,985 institutions reported holding it in 13F filings for Q2 2026, worth $125.2B in total; 3 superinvestors hold it, including Southeastern Asset Management (Longleaf) and Soros Fund Management.

Superinvestors holding ABT, Q2 2026

3 superinvestors report holding Abbott Laboratories on Form 13F, worth $81.4M in total. Weight is Abbott Laboratories's share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding ABT in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
Southeastern Asset Management (Longleaf)Mason Hawkins4.0%840,747$76.3MNew
Soros Fund ManagementGeorge Soros0.1%44,750$4.06MUnchanged
Gardner Russo & QuinnTom Russo<0.1%11,510$1.04MUnchanged

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of ABT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    3 superinvestors holding at quarter end

    New
    Southeastern Asset Management (Longleaf)
    Sold out
    Maverick Capital
  2. Q1 2026

    3 superinvestors holding at quarter end

    New
    Maverick Capital, Soros Fund Management
    Sold out
    Harris Associates (Oakmark)
  3. Q3 2025

    2 superinvestors holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−1.2%)
  4. Q2 2025

    2 superinvestors holding at quarter end

    New
    Harris Associates (Oakmark)
  5. Q2 2024

    1 superinvestor holding at quarter end

    Reduced
    Gardner Russo & Quinn (−0.9%)
  6. Q1 2024

    1 superinvestor holding at quarter end

    Sold out
    Maverick Capital
  7. Q4 2023

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+0.8%)
  8. Q3 2023

    2 superinvestors holding at quarter end

    New
    Maverick Capital
  9. Q2 2023

    1 superinvestor holding at quarter end

    Reduced
    Gardner Russo & Quinn (−1.4%)
    Sold out
    Maverick Capital
  10. Q1 2023

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+25.5%)
  11. Q4 2022

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+62.8%)
  12. Q3 2022

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+11.7%)
  13. Q2 2022

    2 superinvestors holding at quarter end

    Reduced
    Gardner Russo & Quinn (−4.1%), Maverick Capital (−54.9%)
  14. Q1 2022

    2 superinvestors holding at quarter end

    New
    Maverick Capital
  15. Q4 2021

    1 superinvestor holding at quarter end

    Sold out
    Maverick Capital
  16. Q3 2021

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+32.5%), Gardner Russo & Quinn (+2.5%)
  17. Q2 2021

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+38.9%)